• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Potash Market
    Potash News
    Potash Stocks
    • Potash Market
    • Potash News
    • Potash Stocks

    Potash West Announces Scoping Study for Dandaragan Superphosphate Project

    Investing News Network
    Sep. 17, 2013 11:39AM PST
    Potash Investing

    Potash West (ASX:PWN) announced results from a Scoping Study targeting single superphosphate production on its wholly owned Dandaragan Trough Project, located 150km north of Perth in Western Australia.

    Potash West (OTCQX:PWNNY,ASX:PWN) announced results from a Scoping Study targeting single superphosphate production on its wholly owned Dandaragan Trough Project, located 150km north of Perth in Western Australia. The Study confirms technical & financial viability of single superphosphate (SSP) production at the Dandaragan Trough Project, and confirmed the ability to produce commodity grade SSP, as well as an IRR of 26% and low capital costs of $144M, inclusive of indirect costs.

    As quoted in the press release:

    HIGHLIGHTS:
    • Study confirms technical & financial viability of single superphosphate (SSP) production at the Dandaragan Trough Project
    • Phosphate resources at Dinner Hill can support an operation producing over 340,000 tpa of SSP for over 20 years
    • Ability to produce commodity grade SSP confirmed
    • Average Revenues per year of A$131 million
    • Estimated average total annual cash costs of A$97.6 million
    • IRR of 26%
    • NPV8% of A$218 million
    • Low capital costs of $144M, inclusive of indirect costs
    • Payback in under four years
    • Straightforward, established mining method
    • Low cost and simple processing
    • Progressing towards a Definitive Feasibility Study

    Potash West Managing Director Patrick McManus said:

    The significant phosphate potential of the Dinner Hill region of the Dandaragan Trough was recognised as we developed the economics of our patent-pending K-Max process, which produces not just potash, but also phosphate, alum and iron oxide. Capturing the full value of the phosphate allows a viable independent phosphate facility to be considered, in addition to providing major improvements to the economics of a K-Max plant.

    Click here to read the Potash West (ASX:PWN) press release
    Click here to see the Potash West (ASX:PWN) profile.

    asx-pwnwestern-australiaaustraliaotcqx-pwnnypotash-west
    The Conversation (0)

    Go Deeper

    AI Powered

    Wealth Signs Letter Agreement to Acquire Interest in ‘Seven Salars’ Lithium Project in Chile

    Potash West Completes Drilling Program at Dandaragan Trough

    Latest News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES